NeuroMetrix, Inc. (NASDAQ:NURO) Q4 2023 Earnings Call Transcript February 22, 2024 NeuroMetrix, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the NeuroMetrix Fourth Quarter 2023 Business and Financial Update. My name is Josh, and […]
NeuroMetrix (NASDAQ:NURO – Get Free Report) issued its quarterly earnings results on Thursday. The medical device company reported ($1.43) earnings per share (EPS) for the quarter, Zacks reports. NeuroMetrix had a negative net margin of 86.64% and a negative return on equity of 25.71%. The business had revenue of $1.32 million during the quarter. NeuroMetrix […]
StockNews.com initiated coverage on shares of NeuroMetrix (NASDAQ:NURO – Get Free Report) in a research report issued on Monday. The firm set a “sell” rating on the medical device company’s stock. NeuroMetrix Stock Performance NASDAQ:NURO opened at $3.41 on Monday. NeuroMetrix has a 1 year low of $2.85 and a 1 year high of $15.04. […]
StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO – Free Report) in a research note released on Sunday. The firm issued a sell rating on the medical device company’s stock. NeuroMetrix Stock Down 8.6 % Shares of NeuroMetrix stock opened at $3.10 on Friday. NeuroMetrix has a 52-week low of $2.85 and a 52-week high […]
StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO – Get Free Report) in a report issued on Sunday. The firm set a “sell” rating on the medical device company’s stock. NeuroMetrix Trading Up 5.0 % NASDAQ:NURO opened at $3.39 on Friday. The firm has a market cap of $3.63 million, a PE ratio of -0.61 […]